1. Home
  2. GRNQ vs VRAX Comparison

GRNQ vs VRAX Comparison

Compare GRNQ & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$2.23

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.18

Market Cap

1.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
VRAX
Founded
2013
2013
Country
Malaysia
United Kingdom
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
1.7M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
GRNQ
VRAX
Price
$2.23
$0.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
18.2K
161.6K
Earning Date
04-08-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,673,997.00
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.55
N/A
52 Week Low
$0.84
$0.18
52 Week High
$2.50
$1.35

Technical Indicators

Market Signals
Indicator
GRNQ
VRAX
Relative Strength Index (RSI) 69.37 36.65
Support Level $1.57 N/A
Resistance Level $2.50 $0.25
Average True Range (ATR) 0.13 0.02
MACD 0.05 0.00
Stochastic Oscillator 94.29 0.46

Price Performance

Historical Comparison
GRNQ
VRAX

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: